Lorenzo Da Dalt, Giulia Giancane, Francesca Fantini, Laura Castiglioni, Patrizia Uboldi, Silvia Pedretti, Nico Mitro, Annalisa Moregola, Ottavia Terenghi, Luigi Sironi, Andrea Baragetti, Giuseppe Danilo Norata
{"title":"Systemic OPA1 overexpression reshapes cardiovascular metabolism and cardiac physiology during high-fat diet feeding.","authors":"Lorenzo Da Dalt, Giulia Giancane, Francesca Fantini, Laura Castiglioni, Patrizia Uboldi, Silvia Pedretti, Nico Mitro, Annalisa Moregola, Ottavia Terenghi, Luigi Sironi, Andrea Baragetti, Giuseppe Danilo Norata","doi":"10.1016/j.vph.2026.107713","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Optic atrophy 1 (OPA1) is a mitochondrial inner-membrane GTPase that coordinates mitochondrial fusion, cristae organization, and respiratory efficiency. Beyond mitochondrial bioenergetics, OPA1 contributes to cardiovascular homeostasis, including the maintenance of vascular cell function and phenotype. Although increasing OPA1 expression has been proposed to improve mitochondrial performance, the consequences of sustained OPA1-driven oxidative activation in the lipid-exposed cardiovascular system remain incompletely defined. Here, we investigated cardiac structure, tissue metabolism, and cardiomyocyte bioenergetics in mice with systemic OPA1 overexpression maintained on a high-fat diet (HFD).</p><p><strong>Methods: </strong>OPA1-overexpressing mice were fed high-fat diet for 20 weeks, followed by indirect calorimetry and echocardiographic analysis. Tissues were used for OMICs investigation and metabolic analysis.</p><p><strong>Results: </strong>OPA1-overexpressing mice displayed preserved global left-ventricular systolic function and ventricular volumes but presented reduced anterior and lateral wall thickness. Histological analysis further revealed a decrease in cardiomyocyte cross-sectional area accompanied by increased myocardial collagen deposition. Cardiac triglyceride content was elevated, whereas cholesterol content was unchanged. In neonatal cardiomyocytes, OPA1 overexpression resulted in increased oxygen consumption, with the strongest response observed in cells co-incubated with very-low-density lipoprotein. Under this lipid-rich condition, ATP-linked respiration, maximal respiration, and spare respiratory capacity were increased.</p><p><strong>Discussion: </strong>Collectively, these findings indicate that systemic OPA1 overexpression was associated with myocardial lipid accumulation and early fibrotic remodeling during HFD feeding, despite preserved systolic function. In vitro, OPA1 overexpression increased cardiomyocyte respiratory capacity under lipid-rich conditions. These data identify a context-dependent effect of OPA1 in which enhanced respiratory capacity may become maladaptive when lipid supply exceeds coordinated oxidative and storage capacity.</p>","PeriodicalId":23949,"journal":{"name":"Vascular pharmacology","volume":" ","pages":"107713"},"PeriodicalIF":3.7000,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.vph.2026.107713","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Optic atrophy 1 (OPA1) is a mitochondrial inner-membrane GTPase that coordinates mitochondrial fusion, cristae organization, and respiratory efficiency. Beyond mitochondrial bioenergetics, OPA1 contributes to cardiovascular homeostasis, including the maintenance of vascular cell function and phenotype. Although increasing OPA1 expression has been proposed to improve mitochondrial performance, the consequences of sustained OPA1-driven oxidative activation in the lipid-exposed cardiovascular system remain incompletely defined. Here, we investigated cardiac structure, tissue metabolism, and cardiomyocyte bioenergetics in mice with systemic OPA1 overexpression maintained on a high-fat diet (HFD).
Methods: OPA1-overexpressing mice were fed high-fat diet for 20 weeks, followed by indirect calorimetry and echocardiographic analysis. Tissues were used for OMICs investigation and metabolic analysis.
Results: OPA1-overexpressing mice displayed preserved global left-ventricular systolic function and ventricular volumes but presented reduced anterior and lateral wall thickness. Histological analysis further revealed a decrease in cardiomyocyte cross-sectional area accompanied by increased myocardial collagen deposition. Cardiac triglyceride content was elevated, whereas cholesterol content was unchanged. In neonatal cardiomyocytes, OPA1 overexpression resulted in increased oxygen consumption, with the strongest response observed in cells co-incubated with very-low-density lipoprotein. Under this lipid-rich condition, ATP-linked respiration, maximal respiration, and spare respiratory capacity were increased.
Discussion: Collectively, these findings indicate that systemic OPA1 overexpression was associated with myocardial lipid accumulation and early fibrotic remodeling during HFD feeding, despite preserved systolic function. In vitro, OPA1 overexpression increased cardiomyocyte respiratory capacity under lipid-rich conditions. These data identify a context-dependent effect of OPA1 in which enhanced respiratory capacity may become maladaptive when lipid supply exceeds coordinated oxidative and storage capacity.
期刊介绍:
Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system.
Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English.
The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.